Department of Analytical Chemistry, Chair of Analytical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland.
Chair and Department of Biochemistry and Biotechnology, Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland.
Int J Mol Sci. 2021 Mar 13;22(6):2933. doi: 10.3390/ijms22062933.
Osteoporosis is a worldwide chronic disease characterized by increasing bone fragility and fracture likelihood. In the treatment of bone defects, materials based on calcium phosphates (CaPs) are used due to their high resemblance to bone mineral, their non-toxicity, and their affinity to ionic modifications and increasing osteogenic properties. Moreover, CaPs, especially hydroxyapatite (HA), can be successfully used as a vehicle for local drug delivery. Therefore, the aim of this work was to fabricate hydroxyapatite-based composite beads for potential use as local carriers for raloxifene. HA powder, modified with magnesium and silicon ions (Mg,Si-HA) (both of which play beneficial roles in bone formation), was used to prepare composite beads. As an organic matrix, sodium alginate with chondroitin sulphate and/or keratin was applied. Cross-linking of beads containing raloxifene hydrochloride (RAL) was carried out with Mg ions in order to additionally increase the concentration of this element on the material surface. The morphology and porosity of three different types of beads obtained in this work were characterized by scanning electron microscopy (SEM) and mercury intrusion porosimetry, respectively. The Mg and Si released from the Mg,Si-HA powder and from the beads were measured by inductively coupled plasma optical emission spectrometry (ICP-OES). In vitro RAL release profiles were investigated for 12 weeks and studied using UV/Vis spectroscopy. The beads were also subjected to in vitro biological tests on osteoblast and osteosarcoma cell lines. All the obtained beads revealed a spherical shape with a rough, porous surface. The beads based on chondroitin sulphate and keratin (CS/KER-RAL) with the lowest porosity resulted in the highest resistance to crushing. Results revealed that these beads possessed the most sustained drug release and no burst release effect. Based on the results, it was possible to select the optimal bead composition, consisting of a mixture of chondroitin sulphate and keratin.
骨质疏松症是一种全球性的慢性疾病,其特征是骨脆性增加和骨折风险增加。在治疗骨缺损时,由于与骨矿物质高度相似、无毒、对离子修饰和增加成骨性能的亲和力,因此使用基于钙磷酸盐(CaP)的材料。此外,CaP,特别是羟磷灰石(HA),可成功用作局部药物递送的载体。因此,本工作的目的是制备基于羟磷灰石的复合珠,以潜在用作雷洛昔芬的局部载体。使用经过镁和硅离子改性的 HA 粉末(Mg,Si-HA)(这两种离子在骨形成中都发挥有益作用)来制备复合珠。作为有机基质,应用了含有硫酸软骨素和/或角蛋白的海藻酸钠。用 Mg 离子对含有盐酸雷洛昔芬(RAL)的珠进行交联,以进一步增加材料表面上该元素的浓度。通过扫描电子显微镜(SEM)和压汞法分别对三种不同类型的珠的形态和孔隙率进行了表征。通过电感耦合等离子体发射光谱法(ICP-OES)测量了从 Mg,Si-HA 粉末和珠中释放的 Mg 和 Si。通过紫外/可见分光光度法研究了 12 周的 RAL 体外释放曲线。还对成骨细胞和骨肉瘤细胞系进行了珠的体外生物学测试。所有获得的珠均呈球形,表面粗糙,多孔。基于硫酸软骨素和角蛋白的珠(CS / KER-RAL)具有最低的孔隙率,导致抗压强度最高。结果表明,这些珠具有最持久的药物释放,没有突释效应。根据结果,可以选择由硫酸软骨素和角蛋白混合物组成的最佳珠组成。